Nomenclature
CAS number: 68-04-2
2-Hydroxy-1,2,3-propanetricarboxylic acid sodium salt (1:3); trisodium citrate; Citrosodine (GSK); Cystemme (Abbott); Urisal (Sanofi-Synthelabo).
C
6H
5Na
3O
7; mol wt 258.07.
C 27.92%, H 1.95%, Na 26.73%, O 43.40%.
Description and references
Crystal structure of dihydrate: A. Fischer,
G. Palladino, Acta Crystallogr. E59, m1080 (2003). Anticoagulant use in blood transfusion:
R. Weil, J. Am. Med. Assoc. 64, 425 (1915); cf. ibid. 250, 1901 (1983). Toxicity study: C. M. Gruber, Jr., W. A. Halbeisen, J. Pharmacol. Exp. Ther. 94, 65
(1948). Clinical evaluation of antacid efficacy: C. P. Gibbs et al., Anesthesiology 57, 44 (1982); of effects on athletic performance: V. Opik et al., Br. J. Sports Med. 37, 485 (2003).
Properties
LD50 in rats, mice
(mmol/kg): 6.0, 5.5 i.p. (Gruber,
Halbeisen).Derivative
Dihydrate.
Nomenclature
CAS number: 6132-04-3
C
6H
5Na
3O
7.2H
2O; mol wt 294.10.
C 24.50%, H 3.08%, Na 23.45%, O 48.96%.
Properties
White, odorless crystals, granules or powder;
cool, saline taste. Stable in air; becomes anhydrous at 150°. d 1.814. Sol in 1.3
parts water, 0.6 part boiling water. Insol in alcohol. The aq soln
is slightly alkaline to litmus. pH about 8.Use
Anticoagulant for collection of blood. In photography;
as sequestering agent to remove trace metals; as emulsifier, acidulant
and sequestrant in foods. Buffer.
Therapeutic Category
Systemic alkalinizing agent.
Keywords
Alkalinizing Agent